Martens, L.L.

cholesterol disease heart disease heart therapy level study percent serum cholesterol levels serum patient mortality model effect trial reduction serum cholesterol cost-effectiveness framingham study result cholesterol levels life expectancy framingham simvastatin women treatment health analysis netherland cholesterol level estimate infarction prevention increase intervention risk factors incidence person chapter angina pectoris measurement heart disease incidence lipid research clinics group factor journal expectancy heart disease risk number benefit program change framingham heart study serum cholesterol level value pretreatment cholesterol levels medication cholestyramine death 8 mmol /1 pretreatment cholesterol level all-cause mortality blood evaluation research angina assumption lipid hospital sensitivity population relationship american association physician function pretreatment prevention trial pectori cause